# Immune Effects of Vitamin D in Hemodialysis Patients

> **NCT00686751** · PHASE2 · COMPLETED · sponsor: **Renal Research Institute** · enrollment: 20 (actual)

## Conditions studied

- End Stage Renal Disease
- Hemodialysis
- Inflammatory Response
- Cardiovascular Disease

## Interventions

- **DRUG:** paricalcitol

## Key facts

- **NCT ID:** NCT00686751
- **Lead sponsor:** Renal Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** 2007-09
- **Final completion:** 2007-09
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2009-05-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00686751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00686751, "Immune Effects of Vitamin D in Hemodialysis Patients". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00686751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*